Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A1 | P18405 | 14/20 | 0.38 |
| ▸ | SRD5A2 | P31213 | 7/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.38 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | HSD3B1 | P14060 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | THPO | P40225 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7978400 | 1.00 | SRD5A1 (0.38) | SRD5A1SRD5A2LMNACYP3A4CYP2C9 | |
| SCHEMBL9319615 | 0.88 | SRD5A1 (0.37) | SRD5A1SRD5A2LMNACYP3A4CYP2C9 | |
| SCHEMBL9134036 | 0.83 | SRD5A1 (0.52) | SRD5A1SRD5A2LMNACYP3A4CYP2C9 | |
| SCHEMBL9134039 | 0.83 | SRD5A1 (0.52) | SRD5A1SRD5A2LMNACYP3A4CYP2C9 | |
| SCHEMBL7901226 | 0.76 | SRD5A1 (0.55) | SRD5A1SRD5A2LMNACYP3A4CYP2C9 | |
| SCHEMBL7901229 | 0.76 | SRD5A1 (0.55) | SRD5A1SRD5A2LMNACYP3A4CYP2C9 | |
| SCHEMBL9114837 | 0.74 | SRD5A1 (0.43) | SRD5A1SRD5A2LMNACYP3A4CYP2C9 | |
| SCHEMBL7624986 | 0.72 | SRD5A1 (0.69) | SRD5A1SRD5A2LMNACYP3A4CYP2C9 | |
| SCHEMBL8163352 | 0.72 | SRD5A1 (0.69) | SRD5A1SRD5A2LMNACYP3A4CYP2C9 | |
| SCHEMBL7624979 | 0.72 | SRD5A1 (0.69) | SRD5A1SRD5A2LMNACYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6268376-B1 | Method of prevention of prostatic carcinoma with 17β-N-monosubstituted-carbamoyl-4-aza-5α-androst-1-en-3-ones | MERCK & CO., INC. | 2001-07-31 | — | — | US | claimed |
| EP-0674521-A4 | METHOD OF TREATMENT OF CHRONIC PROSTATITIS WITH 17-g(b)-N-MONOSUBSTITUTED-CARBAMOYL-4-AZA-5-g(a)-ANDROST-1-EN-3-ONES. | MERCK & CO INC (US) | 1998-02-04 | — | — | EP | claimed |
| US-5629318-A | Method of treatment of chronic prostatitis with 17β-N-monosubstituted-carbamoyl-4-aza-5α-androst-1-en-3-ones | MERCK & CO., INC. (US) | 1997-05-13 | — | — | US | claimed |
| EP-0674521-A1 | METHOD OF TREATMENT OF CHRONIC PROSTATITIS WITH 17$g(b)-N-MONOSUBSTITUTED-CARBAMOYL-4-AZA-5$g(a)-ANDROST-1-EN-3-ONES | MERCK & CO. INC. (US) | 1995-10-04 | — | — | EP | claimed |
| WO-1994014452-A1 | METHOD OF TREATMENT OF CHRONIC PROSTATITIS WITH 17β-N-MONOSUBSTITUTED-CARBAMOYL-4-AZA-5α-ANDROST-1-EN-3-ONES | MERCK & CO., INC. (US) | 1994-07-07 | — | — | WO | claimed |
| EP-0547691-A1 | The use of 17B-N-mono-substituted-carbamoyl-4-aza-5alpha-androst-1-en-3-ones for the preparation of a medicament for the prevention of prostatic carcinoma | MERCK & CO. INC. (US) | 1993-06-23 | — | — | EP | claimed |